42114 Federal Register / Vol. 82, No. 171 / Wednesday, September 6, 2017 / Notices 

value (‘‘LTFV’’) and to be subsidized by 

the government of China. 

Commencement of Final Phase 

Investigations 

Pursuant to section 207.18 of the 

Commission’s rules, the Commission 

also gives notice of the commencement 

of the final phase of its investigations. 

The Commission will issue a final phase 

notice of scheduling, which will be 

published in the Federal Register as 

provided in section 207.21 of the 

Commission’s rules, upon notice from 

the Department of Commerce 

(‘‘Commerce’’) of affirmative 

preliminary determinations in the 

investigations under sections 703(b) or 

733(b) of the Act, or, if the preliminary 

determinations are negative, upon 

notice of affirmative final 

determinations in those investigations 

under sections 705(a) or 735(a) of the 

Act. Parties that filed entries of 

appearance in the preliminary phase of 

the investigations need not enter a 

separate appearance for the final phase 

of the investigations. Industrial users, 

and, if the merchandise under 

investigation is sold at the retail level, 

representative consumer organizations 

have the right to appear as parties in 

Commission antidumping and 

countervailing duty investigations. The 

Secretary will prepare a public service 

list containing the names and addresses 

of all persons, or their representatives, 

who are parties to the investigations. 

Background 

On July 13, 2017, the Cast Iron Soil 

Pipe Institute, Mundelein, Illinois, filed 

a petition with the Commission and 

Commerce, alleging that an industry in 

the United States is materially injured 

or threatened with material injury by 

reason of LTFV and subsidized imports 

of cast iron soil pipe fittings from China. 

Accordingly, effective July 13, 2017, the 

Commission, pursuant to sections 703(a) 

and 733(a) of the Act (19 U.S.C. 

1671b(a) and 1673b(a)), instituted 

countervailing duty investigation No. 

701–TA–583 and antidumping duty 

investigation No. 731–TA–1381 

(Preliminary). 

Notice of the institution of the 

Commission’s investigations and of a 

public conference to be held in 

connection therewith was given by 

posting copies of the notice in the Office 

of the Secretary, U.S. International 

Trade Commission, Washington, DC, 

and by publishing the notice in the 

Federal Register of July 20, 2017 (82 FR 

33515). The conference was held in 

Washington, DC, on August 3, 2017, and 

all persons who requested the 

opportunity were permitted to appear in 

person or by counsel. 

The Commission made these 

determinations pursuant to sections 

703(a) and 733(a) of the Act (19 U.S.C. 

1671b(a) and 1673b(a)). It completed 

and filed its determinations in these 

investigations on August 28, 2017. The 

views of the Commission are contained 

in USITC Publication 4722 (September 

2017), entitled Cast Iron Soil Pipe 

Fittings from China: Investigation Nos. 

701–TA–583 and 731–TA–1381 

(Preliminary). 

By order of the Commission. 

Issued: August 28, 2017. 

William R. Bishop, 

Supervisory Hearings and Information 

Officer. 

[FR Doc. 2017–18508 Filed 9–5–17; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

Notice of Receipt of Complaint; 

Solicitation of Comments Relating to 

the Public Interest 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission has received a complaint 

entitled Certain Synthetically Produced, 

Predominantly EPA Omega-3 Products 

in Ethyl Ester or Re-esterified 

Triglyceride Form, DN 3247; the 

Commission is soliciting comments on 

any public interest issues raised by the 

complaint or complainant’s filing 

pursuant to the Commission’s Rules of 

Practice and Procedure. 

FOR FURTHER INFORMATION CONTACT: Lisa 

R. Barton, Secretary to the Commission, 

U.S. International Trade Commission, 

500 E Street SW., Washington, DC 

20436, telephone (202) 205–2000. The 

public version of the complaint can be 

accessed on the Commission’s 

Electronic Document Information 

System (EDIS) at https://edis.usitc.gov, 

and will be available for inspection 

during official business hours (8:45 a.m. 

to 5:15 p.m.) in the Office of the 

Secretary, U.S. International Trade 

Commission, 500 E Street SW., 

Washington, DC 20436, telephone (202) 

205–2000. 

General information concerning the 

Commission may also be obtained by 

accessing its Internet server at United 

States International Trade Commission 

(USITC) at https://www.usitc.gov. The 

public record for this investigation may 

be viewed on the Commission’s 

Electronic Document Information 

System (EDIS) at https://edis.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: The 

Commission has received a complaint 

and a submission pursuant to § 210.8(b) 

of the Commission’s Rules of Practice 

and Procedure filed on behalf of Amarin 

Pharma, Inc. and Amarin 

Pharmaceuticals Ireland Ltd. on August 

30, 2017. The complaint alleges 

violations of section 337 of the Tariff 

Act of 1930 (19 U.S.C. 1337) in the 

importation into the United States, the 

sale for importation, and the sale within 

the United States after importation of 

certain synthetically produced, 

predominantly EPA omega-3 products 

in ethyl ester or re-esterified triglyceride 

form. The complaint names as 

respondents Royal DSM NV of The 

Netherlands; DSM Marine Lipids Peru 

S.A.C. of Peru; DSM Nutritional 

Products of Parsippany, NJ; DSM 

Nutritional Products Canada, Inc. of 

Canada; Ultimate Biopharma 

(Zhongshan) Corporation of China; 

Marine Ingredients AS of Norway; 

Marine Ingredients LLC of Bethel, PA; 

Golden Omega S.A. of Chile; Golden 

Omega USA LLC of Aliso Viejo, CA; 

Nordic Pharma, Inc. of Norway; Croda 

Europe Ltd. of The United Kingdom; 

Croda Inc. of Edison, NJ; Tecnologica de 

Alimentos S.A. of Peru; Nature’s Bounty 

of Ronkonkoma, NY; Nordic Naturals of 

Watsonville, CA; Pharmavite LLC of 

Northridge, CA; Innovix Pharma Inc. of 

Calabasas, CA and J.R. Carlson 

Laboratories, Inc. of Arlington Heights, 

IL. The complainant requests that the 

Commission issue a general exclusion 

order, a limited exclusion order, a cease 

and desist order, and impose a bond 

upon respondents’ alleged infringing 

articles during the 60-day Presidential 

review period pursuant to 19 U.S.C. 

1337(j). 

Proposed respondents, other 

interested parties, and members of the 

public are invited to file comments, not 

to exceed five (5) pages in length, 

inclusive of attachments, on any public 

interest issues raised by the complaint 

or § 210.8(b) filing. Comments should 

address whether issuance of the relief 

specifically requested by the 

complainant in this investigation would 

affect the public health and welfare in 

the United States, competitive 

conditions in the United States 

economy, the production of like or 

directly competitive articles in the 


asabaliauskas on DSKBBXCHB2PROD with NOTICES
Federal Register / Vol. 82, No. 171 / Wednesday, September 6, 2017 / Notices 42115 

1Handbook for Electronic Filing Procedures: 

https://www.usitc.gov/documents/handbook_on_

filing_procedures.pdf. 

2All contract personnel will sign appropriate 

nondisclosure agreements. 

3Electronic Document Information System 

(EDIS): https://edis.usitc.gov. 

United States, or United States 

consumers. 

In particular, the Commission is 

interested in comments that: 

(i) Explain how the articles 

potentially subject to the requested 

remedial orders are used in the United 

States; 

(ii) identify any public health, safety, 

or welfare concerns in the United States 

relating to the requested remedial 

orders; 

(iii) identify like or directly 

competitive articles that complainant, 

its licensees, or third parties make in the 

United States which could replace the 

subject articles if they were to be 

excluded; 

(iv) indicate whether complainant, 

complainant’s licensees, and/or third 

party suppliers have the capacity to 

replace the volume of articles 

potentially subject to the requested 

exclusion order and/or a cease and 

desist order within a commercially 

reasonable time; and 

(v) explain how the requested 

remedial orders would impact United 

States consumers. 

Written submissions must be filed no 

later than by close of business, eight 

calendar days after the date of 

publication of this notice in the Federal 

Register. There will be further 

opportunities for comment on the 

public interest after the issuance of any 

final initial determination in this 

investigation. 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above and submit 8 true paper 

copies to the Office of the Secretary by 

noon the next day pursuant to § 210.4(f) 

of the Commission’s Rules of Practice 

and Procedure (19 CFR 210.4(f)). 

Submissions should refer to the docket 

number (‘‘Docket No. 3247’’) in a 

prominent place on the cover page and/ 

or the first page. (See Handbook for 

Electronic Filing Procedures, Electronic 

Filing Procedures.) 1 Persons with 

questions regarding filing should 

contact the Secretary (202–205–2000). 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment. All such requests should be 

directed to the Secretary to the 

Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All such requests 

should be directed to the Secretary to 

the Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this Investigation may be 

disclosed to and used: (i) By the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. Appendix 3; or (ii) by U.S. 

government employees and contract 

personnel,2 solely for cybersecurity 

purposes. All nonconfidential written 

submissions will be available for public 

inspection at the Office of the Secretary 

and on EDIS.3

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and of §§ 201.10 and 210.8(c) of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 201.10, 210.8(c)). 

By order of the Commission. 

Issued: August 30, 2017. 

Katherine M. Hiner, 

Supervisory Attorney. 

[FR Doc. 2017–18773 Filed 9–5–17; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1068] 

Certain Microfluidic Devices; 

Institution of Investigation 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that a 

complaint was filed with the U.S. 

International Trade Commission on July 

31, 2017, under section 337 of the Tariff 

Act of 1930, as amended, on behalf of 

Bio-Rad Laboratories, Inc. of Hercules, 

California and Lawrence Livermore 

National Security, LLC of Livermore, 

California. A supplement to the 

complaint was filed on August 22, 2017. 

The complaint alleges violations of 

section 337 based upon the importation 

into the United States, the sale for 

importation, and the sale within the 

United States after importation of 

certain microfluidic devices by reason 

of infringement of one or more of U.S. 

Patent No. 9,500,664 (‘‘the ’664 patent’’); 

U.S. Patent No. 9,089,844 (‘‘the ’844 

patent’’); U.S. Patent No. 9,636,682 (‘‘the 

’682 patent’’); U.S. Patent No. 9,649,635 

(‘‘the ’635 patent’’); and U.S. Patent No. 

9,126,160 (‘‘the ’160 patent). The 

complaint further alleges that an 

industry in the United States exists as 

required by the applicable Federal 

Statute. 

The complainants request that the 

Commission institute an investigation 

and, after the investigation, issue a 

limited exclusion order and cease and 

desist orders. 

ADDRESSES: The complaint, except for 

any confidential information contained 

therein, is available for inspection 

during official business hours (8:45 a.m. 

to 5:15 p.m.) in the Office of the 

Secretary, U.S. International Trade 

Commission, 500 E Street SW., Room 

112, Washington, DC 20436, telephone 

(202) 205–2000. Hearing impaired 

individuals are advised that information 

on this matter can be obtained by 

contacting the Commission’s TDD 

terminal on (202) 205–1810. Persons 

with mobility impairments who will 

need special assistance in gaining access 

to the Commission should contact the 

Office of the Secretary at (202) 205– 

2000. General information concerning 

the Commission may also be obtained 

by accessing its internet server at 

https://www.usitc.gov. The public 

record for this investigation may be 

viewed on the Commission’s electronic 

docket (EDIS) at https://edis.usitc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Pathenia M. Proctor, The Office of 

Unfair Import Investigations, U.S. 

International Trade Commission, 

telephone (202) 205–2560. 

SUPPLEMENTARY INFORMATION: 

Authority: The authority for institution of 

this investigation is contained in section 337 

of the Tariff Act of 1930, as amended, 19 

U.S.C. 1337 and in section 210.10 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.10 (2017). 

Scope of Investigation: Having 

considered the complaint, the U.S. 

International Trade Commission, on 

August 30, 2017, ordered that— 

(1) Pursuant to subsection (b) of 

section 337 of the Tariff Act of 1930, as 

amended, an investigation be instituted 

to determine whether there is a 

violation of subsection (a)(1)(B) of 


asabaliauskas on DSKBBXCHB2PROD with NOTICES